Company news

Schrodinger, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium

October 22, 2024

Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium

October 8, 2024

Schrödinger Reports Strong Second Quarter 2024 Financial Results

July 30, 2024

Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology

July 25, 2024

Schrödinger to Announce Second Quarter 2024 Financial Results on July 31

July 16, 2024

Schrödinger Reports First Quarter 2024 Financial Results

April 30, 2024

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

April 9, 2024

Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting

March 19, 2024

Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results

February 27, 2024

Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28

February 13, 2024

Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals

January 7, 2024

Schrödinger Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event

December 13, 2023

Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting

December 9, 2023

Schrödinger to Present New Data for SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting

November 1, 2023

Schrödinger Reports Third Quarter 2023 Financial Results

October 31, 2023

Schrödinger to Host Pipeline Day on December 14, 2023

October 29, 2023

Schrödinger to Announce Third Quarter 2023 Financial Results on November 1

October 17, 2023

Schrödinger and Two City University of New York Colleges Awarded $1M NSF Grant to Increase Access to Computational Molecular Modeling Education

September 27, 2023

Schrödinger Reports Second Quarter 2023 Financial Results

August 1, 2023

Schrödinger to Announce Second Quarter 2023 Financial Results on August 2

July 18, 2023

Schrödinger to Present at Goldman Sachs 44th Annual Global Healthcare Conference

May 31, 2023

Schrödinger to Present at Jefferies Global Biopharma Conference

May 25, 2023

Schrödinger Reports Strong First Quarter 2023 Financial Results

May 3, 2023

Schrödinger Publishes Inaugural Corporate Sustainability Report

April 26, 2023

Schrödinger to Announce First Quarter 2023 Financial Results on May 4

April 19, 2023

Schrödinger Reports Strong Fourth Quarter and Full-Year 2022 Financial Results

February 27, 2023

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 16, 2023

Schrödinger Receives $111.3 Million Distribution from Sale of Nimbus’s TYK2 Inhibitor to Takeda

February 13, 2023

Schrödinger to Announce Fourth Quarter and Full-Year 2022 Financial Results on February 28

February 12, 2023

Schrödinger to Present at SVB Securities Global Biopharma Conference

January 30, 2023

Schrödinger Provides Update on Progress Across the Business and Outlines 2023 Company Strategic Priorities

January 8, 2023

Schrödinger Presents New Preclinical Data Supporting Advancement of CDC7 Inhibitor Development Candidate, SGR-2921, at American Society of Hematology 2022 Annual Meeting

December 11, 2022

Schrödinger to Present at Piper Sandler 34th Annual Healthcare Conference

November 20, 2022

Schrödinger to Present at Jefferies 13th Annual London Healthcare Conference

November 6, 2022

Schrödinger To Present New Preclinical Data From Its CDC7 Inhibitor Program At American Society Of Hematology 2022 Annual Meeting

November 2, 2022

Schrödinger Reports Third Quarter 2022 Financial Results

November 2, 2022

Schrödinger to Announce Third Quarter 2022 Financial Results on November 3

October 19, 2022

Schrödinger Hosts Platform Day

October 5, 2022

Schrödinger to Host Platform Day on October 6, 2022

September 19, 2022

Schrödinger to Present at Citi’s 17th Annual BioPharma Conference

August 30, 2022

Schrödinger Reports Inducement Grants To Newly Appointed Chief Financial Officer

August 17, 2022

Schrödinger Appoints Geoffrey Porges as Chief Financial Officer

August 17, 2022

Schrödinger Reports Second Quarter 2022 Financial Results

August 3, 2022

Schrödinger to Announce Second Quarter 2022 Financial Results on August 4

July 20, 2022

Schrödinger Announces FDA Clearance of Investigational New Drug Application for SGR-1505, a MALT1 Inhibitor

June 27, 2022

Schrödinger Convenes Global Educators For Second Annual Educator’s Day

June 21, 2022

Schrödinger to Present at Jefferies Healthcare Conference

June 1, 2022

Schrödinger Announces Appointment of Arun Oberoi to Board of Directors

May 18, 2022

Schrödinger to Present at Citi Biotech Virtual Co-Panel Day

May 12, 2022

Schrödinger Reports First Quarter 2022 Financial Results

May 3, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 21 decks. Every deck is listed under its year.